Free Trial

Chemed Co. (NYSE:CHE) Shares Sold by Canada Pension Plan Investment Board

Chemed logo with Medical background

Canada Pension Plan Investment Board lessened its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 97.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100 shares of the company's stock after selling 3,800 shares during the quarter. Canada Pension Plan Investment Board's holdings in Chemed were worth $53,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in shares of Chemed in the 4th quarter valued at $42,023,000. Signal Advisors Wealth LLC boosted its stake in Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock worth $2,647,000 after buying an additional 1,886 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Chemed by 10.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock valued at $72,149,000 after acquiring an additional 13,394 shares during the last quarter. Bright Rock Capital Management LLC purchased a new stake in shares of Chemed in the 4th quarter valued at approximately $1,060,000. Finally, Fifth Third Bancorp boosted its position in shares of Chemed by 12.1% during the 4th quarter. Fifth Third Bancorp now owns 4,934 shares of the company's stock worth $2,614,000 after purchasing an additional 531 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on CHE shares. Royal Bank of Canada raised their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Get Our Latest Research Report on Chemed

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 3.29% of the stock is currently owned by insiders.

Chemed Trading Up 0.1 %

NYSE:CHE traded up $0.45 during midday trading on Friday, reaching $574.19. The company had a trading volume of 32,822 shares, compared to its average volume of 99,137. The stock's fifty day simple moving average is $589.55 and its 200-day simple moving average is $566.52. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $623.61. The firm has a market capitalization of $8.39 billion, a price-to-earnings ratio of 29.01, a PEG ratio of 2.15 and a beta of 0.49.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company's revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.20 earnings per share. As a group, sell-side analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio (DPR) is 9.74%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines